University of Vermont

College of Medicine

Laboratory for Clinical Biochemistry Research

This page has moved to here!

University of Vermont College of Medicine Laboratory for Clinical Biochemistry Research News



College Welcomes Jensen, Thanks Tracy, in Senior Research Dean Transition (2-05-2016)
New University of Vermont College of Medicine Senior Associate Dean for Research Gordon Jensen, M.D., Ph.D., was officially welcomed to the College at a special reception held February 4, 2016 that also honored the many contributions of Russell Tracy, Ph.D., professor of pathology, who served as interim senior associate dean for research from 2014 until Jensen’s arrival in January 2016.


Unexpected Health Discovery Leads to Blood-Clotting Research Gift (8-13-2015)
Joe Golding, CEO of Advancement Resources, was giving a presentation to faculty and health care providers from the University of Vermont Medical Center, the UVM College of Medicine and the UVM College of Nursing and Health Sciences when Yael Friedman noticed something unusual.
Friedman asked Mary Cushman, M.D. to take a look at Golding’s leg.


Olson Research Shows Life’s Simple 7 May Help Lower Risk for Venous Thrombosis (4-27-2015)
Life’s Simple 7, an assessment tool from the American Heart Association, has proven to be an effective way to track the population’s cardiovascular health in an effort to improve outcomes by 2020. A new study, published in the Journal of the American Heart Association, from a team led by UVM Postdoctoral Fellow Nels Olson, Ph.D. ’11, has shown that a favorable Life’s Simple 7 status also is related to decreased risk from another dangerous but less well-known threat: Venous thromboembolism (VTE).


UVM Lab Is Go-to for Genetic Specimens (3-12-2015)
Precision medicine found the limelight when President Obama unveiled a $215 million initiative to target its growth as part of his 2015 State of the Union Address in January, but for researchers both nationwide and at the University of Vermont, exploring how to best tailor medicine to individual needs has been the focus of their work for years. Whether it’s referred to as precision, personalized or genomic medicine, the goal is the same: to obtain individuals’ detailed genetic information so that both risk and treatment of disease can be dealt with at the most elemental level.


Cushman Blogs about Reducing Stroke and Cardiovascular Disease Risk (2-23-2015)
As the month of February and American Heart Month wrap up at the end of this week, it's important to focus on findings from University of Vermont and other research regarding how to reduce stroke and cardiovascular disease. Mary Cushman, M.D., M.Sc., UVM professor of medicine and hematologist and medical director for the Thrombosis and Hemostasis Program at the UVM Medical Center, recently posted a blog on the subject.


Tracy Coauthors Nature Study on Rare Genetic Mutations Associated with Heart Attack (2-04-2015)
New research findings indicate that LDL – the “bad” cholesterol – may have company as a major risk factor for heart attacks that occur at an early age. The new culprit: a mutation in VLDL – or very low-density lipoprotein – a group of triglyceride-rich lipoproteins. The study is published in the February 5, 2015 issue of Nature


Leading the Heart/Lung Charge: Parsons, Tracy and Cushman Play Major Role in Top Organizations (11-06-2014)
The American Heart Association (AHA); the National Institutes of Health’s (NIH) National Heart, Lung, and Blood Institute (NHLBI); and the International Society on Thrombosis and Haemostasis are among the most influential organizations worldwide in the field of cardiovascular, lung and blood-related science and medicine, and they count among their principals three University of Vermont College of Medicine professors—women who talk energetically about their work, describing it as fun, invigorating, and exciting.


Alexander’s and Cushman’s Study Finds Blood Type and Memory Loss Link (9-10-2014)
People with blood type AB may be more likely to develop memory loss in later years than people with other blood types, according to a study published by Kristine Alexander, Ph.D., postdoctoral fellow in medicine, Mary Cushman, M.D., M.Sc., professor of medicine at the University of Vermont College of Medicine, and colleagues in the September 10, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.


Tracy named Interim Senior Associate Dean for Research (6-30-2014)
University of Vermont College of Medicine Dean Frederick Morin, M.D., has announced that Russell Tracy, Ph.D., professor of pathology and biochemistry, director of the Laboratory for Clinical Biochemistry Research, and former senior associate dean for research and academic affairs for the College of Medicine, will serve as interim senior associate dean for research, effective July 1.


Cushman and Gillett Coauthor Paper on Cardiovascular Risk Factors and Cognition (6-26-2014)
A new study co-authored by University of Vermont Professor of Medicine Mary Cushman, M.D., and medical student Sarah Gillett, Ph.D., links cardiovascular risk factors and cognitive impairment.


Cardiovascular Research Institute Honors Distinguished Investigators (4-17-2014)
The Cardiovascular Research Institute of Vermont (CVRI-VT) at the University of Vermont College of Medicine and The University of Vermont Medical Center introduced six 2014 Distinguished Investigators at its relaunch celebration on April 17: Philip Ades, M.D., professor of medicine and director of cardiac rehabilitation and preventive cardiology; Joseph Brayden, Ph.D., professor of pharmacology; Martin LeWinter, M.D., professor of medicine and director of the heart failure and cardiomyopathy program; George Osol, Ph.D., professor of obstetrics, gynecology and reproductive sciences; Russell Tracy, Ph.D., professor of pathology and director of the UVM Laboratory for Clinical Biochemistry Research; and Kathleen Trybus, Ph.D., professor of molecular physiology and biophysics.


Cushman & Hematology Faculty Promote Greater Understanding of Deep-Vein Thrombosis (3-17-2014)
Each year, between 300,000 and 600,000 Americans are affected by deep-vein thrombosis (DVT), a type of blood clot that forms in a major vein of the leg or, less commonly, in the arms, pelvis, or other large veins in the body. March is National Deep Vein Thrombosis Awareness Month and several University of Vermont/UVM Medical Center clinicians are sharing their knowledge about the condition through social media, a March 24 public educational event, national media interviews, and a recent publication in the American Heart Association journal Circulation.


Cushman introduces Vermont's 2014 recipient of the Crystal Heart Award (1-31-2014)
Frank Ittleman, M.D. was named Vermont’s 2014 recipient of the Crystal Heart Award, which recognizes an individual who has contributed to the mission of the American Heart Association and American Stroke Association. Mary Cushman, M.D., M.Sc., Vermont AHA board chair and UVM professor of medicine, provided remarks about Ittleman at the event.


News Archive

Last modified June 30 2016 11:33 AM